Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic therapy with Photofrin vs 5-aminolevulinic acid for high grade dysplasia in Barrett's oesophagus
2005-005528-15Phase 2Completed
- Sponsor
- University College London
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Barrett's esophagus with high-grade dysplasia (BE-HGD) comparing Aminolevulinic acid photodynamic therapy with Photofrin photodynamic therapy (2 arms). Primary endpoint: Side effect profile comparison between Photofrin and aminolevulinic acid photodynamic therapy. Started Dec 2005; status: completed.
02
Drugs
porfimer sodium5-aminolevulinic acid
03
Conditions
Barrett's esophagus with high-grade dysplasia (BE-HGD)
Beyond the preview
Go deeper on 2005-005528-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005528-15.